companydata.dkcompanydata.dk

PEAK BIOTECH A/S: Financial statements 2025

CVR: 28892152

Source: annual report 2025, Danish Business Authority

01/07/2024 – 30/06/2025

PEAK BIOTECH A/S (CVR 28892152) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 29,437,632 and a net result of DKK 21,861,113 compared with DKK 16,506,232 the year before. That is an increase of 31.2% compared with the year before. Equity in the 2025 report amounted to DKK 43,994,380. The solvency ratio was 46.6%. The company had 5 employees in the financial year.

Gross Profit
DKK 29,437,632
Profit/Loss
DKK 21,861,113
Equity
DKK 43,994,380
Total Assets
DKK 94,507,757
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-29.4 mio.21.9 mio.44 mio.5
2024-22.4 mio.16.5 mio.22.1 mio.-
2023-8 mio.3.4 mio.13.6 mio.4
2022-8.8 mio.4.7 mio.10.7 mio.4
2021-9.1 mio.5.1 mio.11 mio.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PEAK BIOTECH A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About PEAK BIOTECH A/S

PEAK BIOTECH A/S is a Danish company of the type Aktieselskab based in Kvistgård, founded in 2005. The company is registered under the industry Fremstilling af andre maskiner til specielle formål i.a.n.. The management consists of Kim Gejl Vind. The board consists of Jens Ulrik Damgaard (chair), Jacob Nøhr and Kim Gejl Vind. The company is owned by BIOTECH HOLDING ApS and PEAK HOLDING ApS. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 29,437,632 and a net result of DKK 21,861,113 compared with DKK 16,506,232 the year before. Equity in the 2025 report amounted to DKK 43,994,380.

Source: annual report 2025, Danish Business Authority